Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Angiotensin-Converting Enzyme Inhibitors

Known as: Angiotensin Converting Enzyme Antagonists, Angiotensin I-Converting Enzyme Inhibitors, Inhibitors, Angiotensin-Converting Enzyme 
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting… Expand
National Institutes of Health

Related topics

Related topics

46 relations
Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme Inhibitors [MoA]Antihypertensive AgentsIn Blood
Expand

Narrower (37)

Benazepril hydrochloride 20 MG Oral TabletCaptoprilCaptopril / HydrochlorothiazideCilazapril
Expand

Broader (1)

Protease Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively associated with cardiovascular and… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Review
2019
Review
2019
The renin-angiotensin system: going beyond the classical paradigms
Thirty years ago, a novel axis of the renin-angiotensin system (RAS) was unveiled by the discovery of angiotensin-(1−7) [ANG-(1−7… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2019
Review
2019
Duplexed aptamers: history, design, theory, and application to biosensing.
Nucleic acid aptamers are single stranded DNA or RNA sequences that specifically bind a cognate ligand. In addition to their… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2019
Review
2019
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.
Histone deacetylases (HDACs), encompassing at least 18 members, are promising targets for anticancer drug discovery and… Expand
Review
2019
Review
2019
Exploring and comparing adverse events between PARP inhibitors.
Ovarian cancer remains one of the most challenging malignancies to treat. Targeted therapies such as poly (ADP-ribose) polymerase… Expand
Review
2018
Review
2018
Fermentation and germination improve nutritional value of cereals and legumes through activation of endogenous enzymes
Abstract Cereals and legumes are outstanding sources of macronutrients, micronutrients, phytochemicals, as well as… Expand
Review
2018
Review
2018
The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
The renin-angiotensin system (RAS) is a key player in the control of the cardiovascular system and hydroelectrolyte balance, with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
Mechanisms of PARP inhibitor sensitivity and resistance.
BRCA1 and BRCA2 deficient tumor cells are sensitive to inhibitors of Poly ADP Ribose Polymerase (PARP1) through the mechanism of… Expand
Review
2017
Review
2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
BackgroundRenin-angiotensin system (RAS) signaling and angiotensin-converting enzyme 2 (ACE2) have been implicated in the… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2017
Review
2017
The vasoprotective axes of the renin‐angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
&NA; The renin‐angiotensin system (RAS) is undisputedly one of the most prominent endocrine (tissue‐to‐tissue), paracrine (cell… Expand
  • figure 3
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE